Socialiya - Entertainment. Knowledge. Community.
Incyte nears up to $2bn deal for blood disorder biotech Star

US biotech Incyte Pharma is nearing a deal for up to $2bn to buy privately held blood disorder drug...

BUSINESS NEWS June 07, 2026

Incyte nears up to $2bn deal for blood disorder biotech Star

US biotech Incyte Pharma is nearing a deal for up to $2bn to buy privately held blood disorder drug developer Star Therapeutics amid a wave of acquisitions...

2 views 0 likes 0 comments
Share:
US biotech Incyte Pharma is nearing a deal for up to $2bn to buy privately held blood disorder drug developer Star Therapeutics amid a wave of acquisitions...

Author: Financial Times

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya